Literature DB >> 23363637

Stimulation of platelet death by vancomycin.

Syeda T Towhid1, Eva-Maria Schmidt, Alexander Tolios, Patrick Münzer, Evi Schmid, Oliver Borst, Meinrad Gawaz, Evi Stegmann, Florian Lang.   

Abstract

BACKGROUND/AIMS: Side effects of vancomycin, a widely used antibiotic, include thrombocytopenia. The vancomycin-induced thrombocytopenia has been attributed to immune reactions. At least in theory, thrombocytopenia could result in part from the triggering of apoptosis, which results in cell shrinkage and cell membrane scrambling with subsequent phosphatidylserine exposure at the cell surface. The cell membrane scrambling could be initiated by a signaling involving increase of cytosolic Ca(2+) activity, ceramide formation, mitochondrial depolarization and/or caspase activation. Vancomycin has indeed been shown to trigger neutrophil apoptosis. An effect of vancomycin on platelet apoptosis has, however, never been tested. The present study thus explored the effect of vancomycin on platelet activation and apoptosis.
METHODS: Human blood platelets were exposed to vancomycin and forward scatter was utilized to estimate cell volume, annexin V-binding to quantify phosphatidylserine (PS) exposure, Fluo-3 AM fluorescence to estimate cytosolic Ca(2+) activity ([Ca(2+)]i), antibodies to quantify ceramide formation and immunofluorescence to quantify protein abundance of active caspase-3.
RESULTS: A 30 minutes exposure to vancomycin (≥1 µg/ ml) decreased cell volume, triggered annexin V-binding, increased [Ca(2+)]i, activated caspase 3, stimulated ceramide formation, triggered release of thromboxane B2, and upregulated surface expression of CD62P (P-selectin) as well as activated integrin αllbβ3. Annexin V-binding and upregulation of CD62P (P-selectin) and integrin αllbβ3 was significantly blunted by removal of extracellular Ca(2+). Annexin V-binding was not significantly blunted by pan-caspase inhibitor zVAD-FMK (1 µM). In conclusion, vancomycin results in platelet activation and suicidal platelet death with increase of [Ca(2+)]i, caspase-3 activation, cell membrane scrambling and cell shrinkage. Activation and cell membrane scrambling required the presence of Ca(2+), but not activation of caspases.
CONCLUSION: Vancomycin exposure leads to platelet activation and apoptosis.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23363637     DOI: 10.1159/000343353

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  6 in total

1.  Crocin prevents sesamol-induced oxidative stress and apoptosis in human platelets.

Authors:  Ram M Thushara; Mahadevappa Hemshekhar; Manoj Paul; Mahalingam Shanmuga Sundaram; Rohith L Shankar; Kempaiah Kemparaju; Kesturu S Girish
Journal:  J Thromb Thrombolysis       Date:  2014-10       Impact factor: 2.300

2.  Novel sila-amide derivatives of N-acetylcysteine protects platelets from oxidative stress-induced apoptosis.

Authors:  Manoj Paul; Ram M Thushara; Swamy Jagadish; Uzma I Zakai; Robert West; Kempaiah Kemparaju; Kesturu S Girish
Journal:  J Thromb Thrombolysis       Date:  2017-02       Impact factor: 2.300

3.  Vancomycin-induced thrombocytopaenia in a patient with severe pancreatitis.

Authors:  Simon P Rowland; Iain Rankin; Hemant Sheth
Journal:  BMJ Case Rep       Date:  2013-10-16

4.  Preventing Data Ambiguity in Infectious Diseases with Four-Dimensional and Personalized Evaluations.

Authors:  Michelle J Iandiorio; Jeanne M Fair; Stylianos Chatzipanagiotou; Anastasios Ioannidis; Eleftheria Trikka-Graphakos; Nikoletta Charalampaki; Christina Sereti; George P Tegos; Almira L Hoogesteijn; Ariel L Rivas
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

Review 5.  Antibiotic Treatment Protocols and Germ-Free Mouse Models in Vascular Research.

Authors:  Franziska Bayer; Stefanie Ascher; Giulia Pontarollo; Christoph Reinhardt
Journal:  Front Immunol       Date:  2019-09-12       Impact factor: 7.561

6.  Enhanced Orai1 and STIM1 expression as well as store operated Ca2+ entry in therapy resistant ovary carcinoma cells.

Authors:  Sebastian Schmidt; Guoxing Liu; Guilai Liu; Wenting Yang; Sabina Honisch; Stavros Pantelakos; Christos Stournaras; Arnd Hönig; Florian Lang
Journal:  Oncotarget       Date:  2014-07-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.